So many options and maybe, only maybe, so little time. I put out what I thought was a reasonable option on 17 March http://agoracom.com/ir/Resverlogix/forums/discussion/topics/687411-so-what-level-will-the-pp-be-at/?message_id=2142539#message . The more I think of this the more it makes sense for every investor. 

Extend and increase the LoC, extend the existing warrants that expire in Aug., issue more warrants for the increased LoC to cover the risk and do a small PP in inject a little more capital. This gives every shareholder and the company the best possible outcome.

If we have a positive Futility Study result the risk at that point shifts from RVX to BP because once this event happens, the chances of a positive Phase III Trial increase a lot. The potential annual sales for RVX208 are in excess of $5 billion which puts this in the mega blockbuster category. This then begs the question of which BP is not going to get the prize if the trial is successful.

We need 8 to 10 months of funding, maybe.

DYODD

tada